QTMeds

FIRAZYR 30 mg

Clinical Description (Database Summary)

(Hérité de ICATIBANT FRESENIUS 30 mg) (Hérité de ICATIBANT ACCORD 30 mg)

Scientific Sources / References

https://www.ema.europa.eu/en/documents/rmp/firazyr-epar-risk-management-plan_en.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022150Orig1s000MedR.pdf